Home › Funds › Lunate Capital Ltd › NMRA

Lunate Capital Ltd position in NMRA

NEUMORA THERAPEUTICS INC. · Health Care

Lunate Capital Ltd reported holding 2,124,143 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.18% of its reported portfolio and ranking #13 among its reported holdings. Lunate Capital Ltd has disclosed NMRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)2.12M sh
Reported value held$1.27M
Portfolio Weight0.18%
First reportedQ1 2025
Last changeHold
Updated2026-11-05

Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR

How Lunate Capital Ltd's NMRA position evolved

Lunate Capital Ltd first disclosed a stake in NMRA in Q1 2025 at 2,124,143 shares (US$2.1M). The position peaked in Q1 2026 at 2,124,143 shares, worth US$4.1M. Across 7 filings, Lunate Capital Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,124,143 shares valued at US$1.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 2.12M $2.12M New
Q2 2025 2.12M $1.56M Hold
Q3 2025 2.12M $3.87M Hold
Q4 2025 2.12M $3.80M Hold
Q1 2026 2.12M $4.14M Hold
Q2 2026 2.12M $3.61M Hold
Q3 2026 2.12M $1.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NMRA and 13F data

NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 22 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NMRA

All NMRA fund holders →

FAQ

How long has Lunate Capital Ltd held NMRA?

Lunate Capital Ltd has disclosed NMRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Lunate Capital Ltd's current position in NMRA?

As of Q3 2026, Lunate Capital Ltd holds 2.12M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $1.27M, representing 0.18% of its reported portfolio and ranking #13.

Has Lunate Capital Ltd been buying or selling NMRA?

In the latest 13F filing (Q3 2026), Lunate Capital Ltd held unchanged its position in NMRA. The position peaked in Q1 2026 at 2.12M shares.

Which other funds hold NMRA?

Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.